Terazosin
- Product NDC
- 69452-332
- 11-digit product format
- 694520332
- Labeler code
- 69452
- Product ID
- 69452-332_29b9921b-6884-e5bb-e063-6394a90aecf6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bionpharma Inc.
- Application
- ANDA075667
- Marketing category
- ANDA
- Marketing start
- 2024-03-11
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 260376, 313215, 313217, 313219 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69452-332-20 | Terazosin | 100 in 1 BOTTLE | CAPSULE | 100 | | 2 |
| 69452-332-32 | Terazosin | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69452-332 | TERAZOSIN CAPSULE [BIONPHARMA INC.] | 2 | Current NDC, 2 package rows | 20241222_130c84dc-b598-660f-e063-6294a90a8e46.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69452-332-20 | 69452033220 | 100 CAPSULE in 1 BOTTLE (69452-332-20) | 100 capsule | 2024-03-11 | No | No | Current |
| 69452-332-32 | 69452033232 | 1000 CAPSULE in 1 BOTTLE (69452-332-32) | 1000 capsule | 2024-12-20 | No | No | Current |